InfraReDx to demonstrate spectroscopy at TCT

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

InfraReDx, a medical device company, will feature live case demonstrations for the use of its near-infrared (NIR) spectroscopy imaging system at the TransCatheter Cardiovascular Therapeutics (TCT) conference held in Washington, D.C., next week.

The Burlington, Mass.-based InfraReDx said the investigational device uses its NIR spectroscopy in coronary arteries.

The live case will originate from New York-Presbyterian Hospital/Columbia University Medical Center.